Identificationof Dual Agonists of fxr and tgr5 as  potential leads for the type II Diabetes an in Silico and  in Vitro approach

dc.contributor.guide	Srinivasan,P
dc.coverage.spatial
dc.creator.researcher	Sundhu,T
dc.date.accessioned	2017-02-13T08:57:56Z
dc.date.available	2017-02-13T08:57:56Z
dc.date.awarded	17/08/2016
dc.date.completed	08/09/2015
dc.date.registered	09/02/2012
dc.description.abstract	newline
dc.description.note	Summary p.163-166, Reference p.167-200
dc.format.accompanyingmaterial	DVD
dc.format.dimensions
dc.format.extent	ix,201p.
dc.identifier.uri	http://hdl.handle.net/10603/134173
dc.language	English
dc.publisher.institution	Department of Bioinformatics
dc.publisher.place	Karaikudi
dc.publisher.university	Alagappa University
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	fxr and tgr5
dc.subject.keyword	Identificationof Dual Agonists
dc.subject.keyword	in Silico and in Vitro approach
dc.subject.keyword	potential leads
dc.subject.keyword	the type II Diabetes
dc.title	Identificationof Dual Agonists of fxr and tgr5 as potential leads for the type II Diabetes an in Silico and in Vitro approach
dc.title.alternative
dc.type.degree	Ph.D.